These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15697101)

  • 21. Attacking expenditures for asthma.
    Smith MD; McGhan WF
    Bus Health; 1997 Apr; 15(4):67-8, 70. PubMed ID: 10166794
    [No Abstract]   [Full Text] [Related]  

  • 22. Levalbuterol versus albuterol.
    Ameredes BT; Calhoun WJ
    Curr Allergy Asthma Rep; 2009 Sep; 9(5):401-9. PubMed ID: 19671384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to Campbell, Spackman, Sullivan letter to Allergy.
    Brown R; Turk F; Dale P; Bousquet J
    Allergy; 2008 Jun; 63(6):783. PubMed ID: 18445194
    [No Abstract]   [Full Text] [Related]  

  • 24. Cost effectiveness of asthma controller therapies: influence of disease severity and other variables.
    Navarro RP; Parasuraman B
    Manag Care Interface; 2005 Jun; 18(6):31-40. PubMed ID: 16018297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacoeconomics of asthma].
    Jahnz-Rózyk K; Targowski T
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():48-9. PubMed ID: 15524016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.
    Nowak R; Emerman C; Hanrahan JP; Parsey MV; Hanania NA; Claus R; Schaefer K; Baumgartner RA;
    Am J Emerg Med; 2006 May; 24(3):259-67. PubMed ID: 16635694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous salbutamol.
    Shann F
    Pediatr Crit Care Med; 2003 Jan; 4(1):128; author reply 128-9. PubMed ID: 12656565
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost-effectiveness of fluticasone propionate/salmeterol (500/50 microg) in the treatment of COPD.
    Earnshaw SR; Wilson MR; Dalal AA; Chambers MG; Jhingran P; Stanford R; Mapel DW
    Respir Med; 2009 Jan; 103(1):12-21. PubMed ID: 19010652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives.
    O'Connor RD; Gilmore AS; Manjunath R; Stanford RH; Legorreta AP; Jhingran PM
    Curr Med Res Opin; 2006 Mar; 22(3):453-61. PubMed ID: 16574029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Love it or lev it: levalbuterol for severe acute asthma--for now, leave it.
    Kercsmar CM; McDowell KM
    J Pediatr; 2009 Aug; 155(2):162-4. PubMed ID: 19619747
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacoeconomic aspects of bronchial asthma].
    Prosekova EV; Gel'tser BI; Shestovskaia TN
    Ter Arkh; 2000; 72(3):55-8. PubMed ID: 10776656
    [No Abstract]   [Full Text] [Related]  

  • 32. Mechanisms by which S-albuterol induces human bronchial smooth muscle cell proliferation.
    Ibe BO; Abdallah MF; Raj JU
    Int Arch Allergy Immunol; 2008; 146(4):321-33. PubMed ID: 18362475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma.
    Fuhlbrigge AL; Weiss ST; Kuntz KM; Paltiel AD;
    Pediatrics; 2006 Aug; 118(2):e347-55. PubMed ID: 16864642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of current and optimal treatment for adult asthma.
    Simonella L; Marks G; Sanderson K; Andrews G
    Intern Med J; 2006 Apr; 36(4):244-50. PubMed ID: 16640742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analyzing the economy, something is changing concerning asthma].
    Serra Batlles J
    Arch Bronconeumol; 2009 Oct; 45(10):475-7. PubMed ID: 19758739
    [No Abstract]   [Full Text] [Related]  

  • 36. Albuterol vs. levalbuterol for asthma treatment in children.
    Dachs R; Darby-Stewart A; Graber MA
    Am Fam Physician; 2008 May; 77(9):1214-6. PubMed ID: 18540484
    [No Abstract]   [Full Text] [Related]  

  • 37. A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II).
    Sullivan SD; Lee TA; Blough DK; Finkelstein JA; Lozano P; Inui TS; Fuhlbrigge AL; Carey VJ; Wagner E; Weiss KB
    Arch Pediatr Adolesc Med; 2005 May; 159(5):428-34. PubMed ID: 15867115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nebulisers or spacers for the administration of bronchodilators to those with asthma attending emergency departments?
    Mason N; Roberts N; Yard N; Partridge MR
    Respir Med; 2008 Jul; 102(7):993-8. PubMed ID: 18396026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study.
    Weiss K; Buxton M; Andersson FL; Lamm CJ; Liljas B; Sullivan SD
    Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():21-7. PubMed ID: 16573705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
    Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.